Advisory Research’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,087
Closed -$643K 373
2022
Q3
$643K Buy
25,087
+150
+0.6% +$3.85K 0.06% 207
2022
Q2
$593K Buy
+24,937
New +$593K 0.06% 207
2018
Q1
Sell
-64,423
Closed -$1.16M 382
2017
Q4
$1.16M Buy
64,423
+13,398
+26% +$242K 0.02% 264
2017
Q3
$985K Sell
51,025
-56,411
-53% -$1.09M 0.02% 312
2017
Q2
$1.27M Sell
107,436
-52,783
-33% -$623K 0.02% 285
2017
Q1
$1.76M Buy
+160,219
New +$1.76M 0.03% 263